We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market
Read MoreHide Full Article
In the latest trading session, HCA Healthcare (HCA - Free Report) closed at $311.03, marking a -0.91% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.58%. At the same time, the Dow lost 0.12%, and the tech-heavy Nasdaq lost 1.15%.
Shares of the hospital operator have depreciated by 5.02% over the course of the past month, outperforming the Medical sector's loss of 6.07% and lagging the S&P 500's loss of 1.09%.
The upcoming earnings release of HCA Healthcare will be of great interest to investors. The company's earnings report is expected on April 26, 2024. The company is expected to report EPS of $5.01, up 1.62% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $16.84 billion, up 8.04% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $20.58 per share and a revenue of $69.03 billion, indicating changes of +8.26% and +6.25%, respectively, from the former year.
Any recent changes to analyst estimates for HCA Healthcare should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.43% higher. HCA Healthcare is currently sporting a Zacks Rank of #2 (Buy).
In the context of valuation, HCA Healthcare is at present trading with a Forward P/E ratio of 15.25. This indicates a discount in contrast to its industry's Forward P/E of 15.43.
Meanwhile, HCA's PEG ratio is currently 1.51. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Medical - Hospital industry stood at 1.81 at the close of the market yesterday.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 98, putting it in the top 39% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market
In the latest trading session, HCA Healthcare (HCA - Free Report) closed at $311.03, marking a -0.91% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.58%. At the same time, the Dow lost 0.12%, and the tech-heavy Nasdaq lost 1.15%.
Shares of the hospital operator have depreciated by 5.02% over the course of the past month, outperforming the Medical sector's loss of 6.07% and lagging the S&P 500's loss of 1.09%.
The upcoming earnings release of HCA Healthcare will be of great interest to investors. The company's earnings report is expected on April 26, 2024. The company is expected to report EPS of $5.01, up 1.62% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $16.84 billion, up 8.04% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $20.58 per share and a revenue of $69.03 billion, indicating changes of +8.26% and +6.25%, respectively, from the former year.
Any recent changes to analyst estimates for HCA Healthcare should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.43% higher. HCA Healthcare is currently sporting a Zacks Rank of #2 (Buy).
In the context of valuation, HCA Healthcare is at present trading with a Forward P/E ratio of 15.25. This indicates a discount in contrast to its industry's Forward P/E of 15.43.
Meanwhile, HCA's PEG ratio is currently 1.51. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Medical - Hospital industry stood at 1.81 at the close of the market yesterday.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 98, putting it in the top 39% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.